
Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
Date: February 19 - February 22, 2015
Description:
Event type: Conference
Event Address: Greater Columbus Convention Center
Sponsor: Ohio VMA
For More Information:Krysten Pyles,Ohio Veterinary Medical Association
800-662-6862, [email protected]





